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Aim: The aim of this paper was to present diagnostic methods helping in the recognition of
mycosis fungoides (MF) and Sezary syndrome (SS).
Background: Mycosis fungoides is the most common form of primary cutaneous T-cell
lymphomas. It is characterized by a distinctive long-term course and malignant T-cell pro-
liferation. MF diagnosis is not easy, mainly due to the atypical clinical presentation of the
disease at an early stage.
Materials and methods: Low speciﬁc changes, which can be observed at the histopatholog-
ical  examination. Initially, the skin lesions may resemble psoriasis, atopic dermatitis or
chronic eczema. Patients are qualiﬁed according to the available, and generally accepted
WHO-EORTC classiﬁcation, based on a combination of clinical and histopathological mark-
ers.  From a clinical point of view, it is also important to carry out the qualiﬁcation according
to  the TNMB assessment, which allows to specify the stage of the disease, and is helpful in
the  monitoring of the course of disease and therapeutic effects.Results: In this paper we try to present currently available diagnostic methods.
Conclusion: Diagnosis of MF and SS still causes many problems due to less characteristic
changes in the early stage of disease and requires wide interdisciplinary knowledge.
©  2013 Greater Poland Cancer Centre. Published by Elsevier Urban & Partner Sp. z o.o.
historical resemblance to MF. Stationary parapsoriasis, also1.  Background
Mycosis fungoides (MF) is the most common form of primary
cutaneous T-cell lymphomas. It is characterized by a distinc-
tive long-term course and malignant T-cell proliferation.1 MF
diagnosis can be difﬁcult, sometimes even impossible at early
stages of the disease, because both clinically and histologically
it suggests a diagnosis of mild inﬂammatory changes in the
skin.2 The phase of parapsoriasis, which frequently precedes
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changes typical for MF, is classiﬁed by some researchers as a
separate disease, but there are also experts who  incorporate
this condition to the stage of premycoticum. So far, there two
forms of parapsoriasis have been identiﬁed: the progressive
and the stationary. The progressive stage is called premy-
coticum phase due to the clinical nature of skin lesions and
3owski University of Medical Sciences in Poznan´, Przybyszewskiego
known as chronic persistent dermatitis, is characterized by
the presence of benign changes as well as the risk of malignant
transformation, and the transformation in MF  is very small.4
ed by Elsevier Urban & Partner Sp. z o.o. All rights reserved.
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Table 1 – The classiﬁcation of primary cutaneous
lymphomas according to the WHO-EORTC.1
Primary cutaneous T-cell and NK-cell lymphomas
Mycosis fungoides
Variants of mycosis fungoides:
Folliculotropic mycosis fungoides
Pagetoid reticulosis
Granulomatous slack skin
Sezary syndrome
Leukemia/adult T-cell lymphoma
Primary cutaneous CD30+ T-cell lymphoproliferative hyperplasias
Primary cutaneous CD30+ anaplastic large T-cell lymphoma
Lymphomatoid papulosis
Subcutaneous panniculitis-like T-cell lymphoma
Extranodal NK/T-cell lymphoma, nasal type
Primary cutaneous peripheral T-cell lymphomas, unclassiﬁed
Primary cutaneous aggressive epidermotropic CD8+ T-cell
lymphoma
Cutaneous / T-cell lymphoma
Primary cutaneous small/medium CD4+ T-cell lymphoma
Primary cutaneous B-cell lymphomas
Primary cutaneous marginal zone B-cell lymphoma
Primary cutaneous follicular lymphoma
Primary cutaneous diffuse large-cell lymphoma, leg type
Primary cutaneous diffuse large B-cell lymphoma, other types
Intravascular large B-cell lymphomareports of practical oncology an
kin lesions in the case of parapsoriasis, otherwise known as
rocq disease, are round or oval erythematous stains, occur-
ing mainly on the torso and lower limbs, gently exfoliating
ith a diameter of about 5 cm.4 Histopathological examina-
ion shows a few speciﬁc changes, the epidermis undergoes
nly minor changes in the form of spongiform degeneracy,
arakeratosis or acanthosis. In the dermis, one can observe
 minimal perivascular lymphocytic inﬁltration. On the other
and, one cannot observe exocytosis or atypical lymphocytes.
he inﬁltration consists mainly of helper T-cells CD4+, while
he test of gene rearrangements does not show clonality. The
isease which is chronic, greatly improves in the summer
ime, after exposure to the sun. Cases typical in terms of
linical and histological presentation do not undergo the pro-
ression to MF,  but one can ﬁnd single cases of transformation.
herefore, special attention should be paid to patients with
n atypical course of the Brocq disease, and they should be
onitored more  often. The form of progressive plaque parap-
oriasis is characterized by the presence of changes, including
rythematous stains of irregular shape, with a tendency to
pread to the size of 9–10 cm.  Changes occur mainly on the
orso, buttocks, axillary and inguinal region. Some patients
ay experience increased symptoms of itching of the skin,
hich may suggest a transformation into MF. Histopatholog-
cal examination shows perivascular lymphocytic inﬁltration
ithout the presence of atypical cells. In the germinative layer,
here is a soft hydropic degeneration. There may be a cell
xocytosis. At the moment of occurrence of Pautier’s microab-
cesses or cells with cerebrum-shaped nuclei, the image  raises
 suspicion of mycosis fungoides. In the case of patients with
hanges suggesting a progressive plaque parapsoriasis, the
eriod of transformation to MF  lasts for years, and samples
re often collected from patients even several times before
here is a clear diagnosis. Molecular studies are not carried out
or suspected progressive parapsoriasis; usually there is not
nough amount of cellular inﬁltration to perform this type of
iagnosis. The occurrence of inﬁltration, nodules or atrophy
ithin erythematous changes may indicate a progression of
he disease. The prognosis for this condition is good, changes
re unaltered for many  years, are limited and respond well to
xternal treatment. However, one must remember, that at the
ime of diagnose there is always a risk of transition to MF, and
herefore it is so important to have periodic follow-up at the
ermatology clinic. An effective method of treatment is the
se of phototherapy with UVB or PUVA (psoralens + UVA). In
ddition, it is signiﬁcant to make an external use of emollients
nd glucocorticoids.
.  Diagnosis  of  mycosis  fungoides  and
ezary  syndrome
F  diagnosis is not easy, mainly due to the atypical clini-
al presentation of the disease at an early stage, and to low
peciﬁc changes, which can be observed in histopathology.
nitially, the skin lesions may resemble psoriasis, atopic der-
atitis or chronic eczema. The diagnostic procedure begins
ith the thorough case history collection, description of der-
atological state, and, in the next step, a sample is collected
or histopathology. Patients are qualiﬁed according to theNeoplasms of precursor cells
Blastic plasmacytoid dendritic cell neoplasm
available, and generally accepted WHO-EORTC classiﬁcation,
based on a combination of clinical and histopathological
markers (Table 1).1
Initially, the literature presented reports of two  forms of
CTCL or MF and SS. At last, the rapid development of research
in this area, mainly diagnostic tests, contributed to the cre-
ation of the currently existing divisions and classiﬁcations.
Although, in recent years, one has managed to show the cri-
terion for the assessment using the immunohistochemistry,
molecular studies; however, the histopathological image  is
still a very important part of diagnosis in these dermatoses.
During the erythematous phase, MF histopathology is often
not diagnostic; it shows signs of inﬂammation. In case of CTCL,
a histopathological examination shall be performed every few
months, in order to get a diagnosis, or if the diagnosis has
been clearly deﬁned – in order to monitor the disease. At
the inﬁltration stage, in the histopathological image,  one may
observe more  typical features of mycosis fungoides. We  can
see a dense subepidermal cellular inﬁltration, which pans
out like strips, with features of ephidermotropism (i.e. inﬁl-
trating of the cells into the epidermis). Inﬂammatory cells
are small and medium-sized lymphocytic cells with hyper-
chromatic, irregular nuclei. There may also occur other cells,
including mainly histiocytes, plasma cells or eosinophils.5
In the histopathological image  one can also observe Lutzner
cells, larger than the other inﬂammatory cells, described by
some researchers as mycosis fungoides cells or Sezary cells.
They are characterized by dark-colored, lobed, folded nucleus,
the shape of which resembles convolutions (nucleus cerebri-
formis). The presence of Pautrier abscesses, i.e. clusters of
atypical lymphoid cells, is characteristic of the MF inﬁltration
stage. During the MF lumpy phase, cell inﬁltrations include
deep layers of the skin, as well as subcutaneous tissue. At
nd ra74  reports of practical oncology a
this stage of the disease, the inﬁltration is abundant and one
cannot often observe the incidence of the epidermotropism.
In turn, at the late stages of the disease beyond the SS cells,
there may occur a plurality of cells characterized by signif-
icant pleomorphism (Reed–Sternberg-like), which can cause
diagnostic problems, as well as differentiation of other lym-
phomas, including Hodgkin’s lymphoma.6
In case of MF, lymphocytes are characterized by the fol-
lowing phenotype CD3+CD4+CD5+CD8−, and less often by
CD4−CD8+ or CD4−CD8− forms. During the progression of the
disease, there may be a loss of T-cell antigenic characteris-
tics, and occurrence of the CD30+ expression.7 There may also
occur a transition of the MF  form into CD30+ anaplastic large
cell lymphoma, or another lymphoma with a higher malig-
nancy.
The MF  form with alopecia mucinosa is characterized by
the lack of epidermotropism in the histopathological exam-
ination, but there is a mucoid degeneration of hair follicles.
The observed inﬂammatory inﬁltration consists of small and
medium-sized hyperchromatic lymphocyte cells with a shape
resembling the brain, plasma cells and eosinophils. In the
Woringer-Kolopp form, the main feature of the histopathologi-
cal image  is the presence of cells resembling those from Paget’s
disease. They have a metastatic nature and occur in hyperk-
eratotic and acanthotic epidermis. They may also be observed
around the hair follicles and apocrine sweat glands. In the
dermis, mainly perivascularly, one may observe the presence
of inﬁltration composed of small lymphocytes and histiocytic
cells. Pagetoidal cells exhibit a phenotype of CD3+ and CD4+,
and some of them, CD8+.8 The form of the granulomatous
sagging of the skin, described by Ackerman in 1968 in the
histopathological image,  is stated by the presence of a dense
inﬁltration consisting of the CD4+ T-cells with cerebrum-
shaped nuclei. The inﬁltration also consists of polynuclear
giant cells containing lymphocytes and elastin fragments.9,10
In Sezary syndrome, the histopathological image  can be
very distinctive and may be similar to MF. One should pay
attention to a very common lack of the epidermatropism and
monotony in the image  of inﬁltration. The presence of Sezary
cells, both in the lesion taken from the affected area, as well
as in the blood, allow us to lean toward the diagnosis of SS.
The inﬁltration present in the lymph nodes may be spilled or
show the characteristics of lymphadenitis dermatopathica.11
Histopathological image  of the CTCL CD30− lymphoma is
characterized by the presence of diffuse inﬁltration consist-
ing of medium-sized and large cells with cerebrum-shaped
and non-cerebrum shaped nuclei, often without signs of
epidermotropism. In turn, in pleomorphic CTCL with small
and medium-sized cells in the histopathological image,  one
may see diffuse, dense inﬁltration with involvement of the
subcutaneous tissue and epidermotropism. In the inﬁltration,
the presence of large pleomorphic lymphocytes does not
exceed 30%. In the form of primary skin lymphoma, from
the T-cells of the cellulitis, in the image  there predominate
pleomorphic T-cells of different sizes, as well as castration
macrophages. There are occupied lobules of the fat layer
with a visible necrosis, collapsed nuclei and lymphocytes
surrounding fat cells. In the case of NK/T cell lymphomas, a
small percentage shows the phenotype of NK cells, expressing
the CD56 surface antigen. Inﬁltration is observed at differentdiotherapy 1 9 ( 2 0 1 4 ) 72–76
levels of the dermis, and it consists of lymphocytes, plasma
cells, eosinocytes and, occasionally, large atypical cells.
Inﬁltration cells show a phenotype of CD2+CD56+CD3− in
the surface reaction, and CD3+CD4−CD8−CD16−CD57− in the
cytoplasmic reaction. Also very characteristic is the lack of
the TCR gene rearrangement. In turn, the histopathological
image  of primary cutaneous epidermotropic lymphoma from
CD8+ cells, with an aggressive course, which characterizes
strongly epidermotropic and tight-band inﬁltrations, con-
sisting of small or medium-sized pleomorphic T-cells with
the CD3+CD4−CD7+/−CD8+CD45RA+ phenotype. One should
remember that in early stages of the disease the histopatho-
logical examination result may not raise the suspicion of
CTCL. Therefore, it is so important to collect a sample from
the affected area from a patient who has not been treated
for at least two weeks. The test sample must be collected
quite deeply, in the most inﬁltrated area, without evidence
of metastatic eczema, such as mutilations and lacerations.
Another signiﬁcant point in the CTCL diagnosis is the run of
a test using immunohistochemical techniques, providing us
with valuable information about the examined hyperplasia.
One should take into account the analysis of antigens located
on cells, intracellularly or within the structural elements of
the stroma.12 In the course of tests, using monoclonal anti-
bodies, one has the ability to identify the antigens. Discussion
about the speciﬁcs of the CD seems difﬁcult if the majority
of them occur on the surface of cells in various stages of
development. In the diagnosis of cancer, the demonstration
of the presence of different CDs allows us to show the cell line
from which they come from, as well as the stage of develop-
ment at which they are. This test helps to detect individual
cancer cells, which was used among others in the diagnosis
of proliferative diseases, including mainly leukemias. The
term ‘CD’ is very important and useful in the assessment and
classiﬁcation of primary cutaneous T-cell lymphomas.13 In
most cases of CTCL, the following antigens were found on
the surface of cancer lymphoid cells: CD2, CD3, CD4 or CD8.
Together with the progression of the disease, there is a loss
of CD antigens belonging to the T-pan group. In most cases,
atrophy occurs in CD7, CD2 and CD5, but rarely CD3 and TCR
receptor antigens. In case of doubt, when in a differential
diagnosis one takes into account the pseudo-lymphomatous
growth, the diagnosis may be made based on an early loss
of CD7, which clearly speaks in favor of the CTCL diagnosis.
More than 75% of inﬂammatory cells show the presence of
CD30, which is tantamount to the diagnosis of CTCL CD30+.
Immunohistochemical examination also plays an important
role in extranodal lymphomas from NK/T cells. The presence
of CD2, CD56 and CD3 found in the cytoplasm conﬁrms the
diagnosis.14
This study shall be performed in order to complete the
histopathological examination and in cases of doubt, when
the clinical picture does not give us a clear diagnosis. In case
of pseudo-lymphoma suspicion, it gives a chance to perform
a differential diagnosis. This examination is already treated
as a diagnostic ‘gold standard’ in cases of clinical suspicion of
CTCL.
The molecular studies performed in order to diagnose sus-
pected CTCL include the CTCL gene rearrangement. In case of
healthy individuals, there occurs a clonality of the TCR gene
reports of practical oncology and radiotherapy 1 9 ( 2 0 1 4 ) 72–76 75
Table 2 – The TNMB classiﬁcation of mycosis fungoides
and Sezary syndrome according to the ISCL/EORTC.15
Skin
T1 Patches, papules and/or plaques covering <10% of the
body surface area
T1a Only patches
T1b Patches and plaques
T2 Patches, papules and/or plaques covering <10% of the
body surface area
T3 Tumor (one or more, <1 cm diameter)
T4 Erythroderma (<80% of the body surface area)
Lymph nodes
N0 No clinically abnormal peripheral lymph nodes
(cervical, supraclavicular, epitrochlear, axillary,
inguinal; central lymph nodes are not classiﬁed); biopsy
not required
N1 Clinically abnormal (ﬁrm, irregular, clustered or > 1.5 cm
diameter) lymph nodes, histopathology: according to
NCI–LN0-2 or Dutch classiﬁcation – grade 1
N1a Molecular examination: clone negative
N1b Molecular examination: clone positive
N2 Clinically abnormal lymph nodes, histopathology:
according to NCI–LN3 or Dutch classiﬁcation – grade 2
N2a Molecular examination: clone negative
N2b Molecular examination: clone positive
N3 Clinically abnormal lymph nodes, histopathology:
according to NCI–LN4 or Dutch classiﬁcation – grade
3–4; clone positive or negative
Nx Clinically abnormal lymph nodes; no histopathological
examination
Visceral organ involvement
M0 No visceral organ involvement
M1 Visceral organ involvement
Peripheral blood involvement
B0 5% of peripheral blood lymphocytes are atypical Sezary
cells
B0a Clone negative
B0b Clone positive
B1 5% of peripheral blood lymphocytes are atypical Sezary
cells; the amount does not meet the criteria of B2
B1a Clone negative
B1b Clone positive
B2 <1000/L Sezary cells with clone positive in peripheral
blood
or
Proliferation of CD3+ or CD4+ cells in the ratio
CD4/CD8 > 10
or
Proliferation of CD4+ cells with abnormal phenotype
(without CD7 and CD26)
T-cell clone is deﬁned by PCR or Southern blot analysis of the
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Table 3 – ISCL/EORTC revision to the staging of mycosis
fungoides and Sezary syndrome.15
T N M B
IA 1 0 0 0, 1
IB 2 0 0 0, 1
IIA 1–2 1,2 0 0, 1
IIB 3 0–2 0 0, 1
IIIA 4 0–2 0  0
IIIB 4 0–2 0  1
IVA1 1–4 0–2 0 2
IVA2 1–4 3 0 0–2
and hematologists. It seems reasonable to follow the rule ‘ﬁrst
of all I do not harm’, especially when we  have to deal withT-cell receptor gene
n different regions, in the case of CTCL one may observe the
onoclonality of chromosome 7 ( strands) or chromosome
4 ( strands). The performance of this type of study is par-
icularly useful at an early stage of the disease, to conﬁrm the
iagnosis.
From a clinical point of view, it is also important to carry
ut the qualiﬁcations according to the TNMB assessment,
hich allows to specify the stage of the disease, and is help-ul in monitoring the course of disease and therapeutic effects
Tables 2 and 3).15IVB 1–4 0–3 1 0–2
T – tumor; N – nodulus; M – metastases; and B – blood.
It seems, therefore, that a diagnostic algorithm of the pro-
cedure shall include the following steps:
• Collecting a sample from the lesion in order to perform
(often repeatedly):
- Histopathological assessment.
- Immunohistochemical assessment.
- TCR gene rearrangement.
• Laboratory tests: complete blood count, liver function
parameters, LDH and ﬂow cytometry.
• Imaging examinations, including the chest X-ray and com-
puted tomography of the abdomen.
• Ultrasound of lymph nodes with possible lymph node
biopsy or collection of a sample for the histopathological
assessment.
• Bone marrow biopsy.
• Trepanobiopsy.
The SS is characterized by a number of symptoms, includ-
ing: erythrodemic, generalized lymphadenopathy and the
presence of Sezary cells in the peripheral blood, lymph nodes
and skin. Due to the emergence of erythroderma state in
dermatology, in many  other dermatoses, one has accepted
diagnostic criteria in order to distinguish these forms. In the
case of the SS, an absolute number of SS cells in periph-
eral blood shall be greater than 1000 cells/mm2, they should
be present in the immunophenotypic examination (CD4/CD8
lymphocytes ratio is greater than 10 and/or there is an absence
of CD2, CD3, CD4 and/or CD5 lymphocytes), as well as detec-
tion of the Sezary cells clone in the peripheral blood, using the
cytogenic or molecular methods.16
3.  Conclusion
In recent years, a great deal of work have been made work in
the area of the diagnosis of CTCL. The implementation of mod-
ern methods allows the clinicians to clarify earlier diagnosis,
and, what is more,  enable then to start an accurate treatment.
It shall be noted that CTCL is a multidisciplinary approach,
based not only on a common diagnosis, but also appropri-
ate therapy involving dermatologists, oncologists, radiologistspatients with suspected CTCL. And so, let this thought accom-
pany not only all the clinicians, but also diagnosticians who
nd ra
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have a closer look at the patient with suspected primary cuta-
neous T-cell lymphoma.
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